These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20850826)

  • 1. Editorial comment.
    Combs AJ
    J Urol; 2010 Nov; 184(5):2133. PubMed ID: 20850826
    [No Abstract]   [Full Text] [Related]  

  • 2. Vesicoureteral reflux and primary bladder neck dysfunction in children: urodynamic evaluation and randomized, double-blind, clinical trial on effect of α-blocker therapy.
    Kajbafzadeh AM; Baradaran N; Sadeghi Z; Tourchi A; Saeedi P; Madani A; Ataei N; Taghavinejad AM; Mohsseni MJ
    J Urol; 2010 Nov; 184(5):2128-33. PubMed ID: 20850812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New in Austria approved specialty drugs and new knowledge regarding currently available specialty drugs. Uroflo].
    Wien Klin Wochenschr; 1995; 107(15):472-6. PubMed ID: 7545857
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Austin PF
    J Urol; 2010 Feb; 183(2):730. PubMed ID: 20022040
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of terazosin on functional bladder outlet obstruction in women: a pilot study.
    Kessler TM; Studer UE; Burkhard FC
    J Urol; 2006 Oct; 176(4 Pt 1):1487-92. PubMed ID: 16952666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction: a stratified analysis.
    Witjes WP; Rosier PF; Caris CT; Debruyne FM; de la Rosette JJ
    Urology; 1997 Feb; 49(2):197-205; discussion 205-6. PubMed ID: 9037281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates.
    Lepor H; Nieder A; Feser J; O'Connell C; Dixon C
    Urology; 1997 Mar; 49(3):476-80. PubMed ID: 9123722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it.
    Rossi C; Kortmann BB; Sonke GS; Floratos DL; Kiemeney LA; Wijkstra H; de la ROSETTE JJ
    J Urol; 2001 Jan; 165(1):38-41. PubMed ID: 11125359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
    Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
    J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urodynamic study of the lower urinary tract. XII. The effect of prazosin hydrochloride in the treatment of prostatic obstruction and etiology of unstable bladder].
    Takita T; Otani T; Kondo A; Mitsuya H
    Nihon Hinyokika Gakkai Zasshi; 1983 Jan; 74(1):1-14. PubMed ID: 6134856
    [No Abstract]   [Full Text] [Related]  

  • 12. The effectiveness of terazosin, an alpha1-blocker, on bladder neck obstruction as assessed by urodynamic hydraulic energy.
    Yamanishi T; Yasuda K; Sakakibara R; Hattori T; Tojo M
    BJU Int; 2000 Feb; 85(3):249-53. PubMed ID: 10671877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment.
    Combs AJ
    J Urol; 2011 May; 185(5):1868-9. PubMed ID: 21421226
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment.
    Combs AJ
    J Urol; 2009 Nov; 182(5):2453-4; discussion 2454. PubMed ID: 19765762
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary bladder neck dysfunction in children and adolescents III: results of long-term alpha-blocker therapy.
    Van Batavia JP; Combs AJ; Horowitz M; Glassberg KI
    J Urol; 2010 Feb; 183(2):724-30. PubMed ID: 20022041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment on: Intraprostatic and bladder-neck botulinum A toxin in treatment of males with bladder-neck dyssynergia: a pilot study.
    Michel M
    Eur Urol; 2008 Mar; 53(3):626-7. PubMed ID: 17950523
    [No Abstract]   [Full Text] [Related]  

  • 17. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on "Wada N, Kita M, Hashizume K, et al. Urodynamic effects of dutasteride add-on therapy to alpha-adrenergic antagonist for patients with benign prostatic enlargement: prospective pressure-flow study. Neurourol Urodyn 2013;32:1123-7".
    Oelke M
    Neurourol Urodyn; 2013 Nov; 32(8):1128-9. PubMed ID: 23192914
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: Intraprostatic and bladder-neck injection of botulinum A toxin in treatment of males with bladder-neck dyssynergia: a pilot study.
    Pickard R
    Eur Urol; 2008 Mar; 53(3):626. PubMed ID: 17950524
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.